These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24679999)

  • 1. What's new in objective assessment and treatment of facial hyperpigmentation?
    Molinar VE; Taylor SC; Pandya AG
    Dermatol Clin; 2014 Apr; 32(2):123-35. PubMed ID: 24679999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Literature Review of Treatment Outcomes for Lichen Planus Pigmentosus, Erythema Dyschromicum Perstans, and Ashy Dermatosis.
    Wu A; Vaidya S
    J Cutan Med Surg; 2018; 22(6):643-645. PubMed ID: 30322299
    [No Abstract]   [Full Text] [Related]  

  • 3. A Delphi consensus on the nomenclature and diagnosis of lichen planus pigmentosus and related entities.
    Sarkar R; Vinay K; Bishnoi A; Poojary S; Gupta M; Kumaran MS; Jain A; Gurumurthy C; Arora P; Kandhari R; Rathi S; Zawar V; Gupta V; Ravivarma VN; Rodrigues M; Parsad D
    Indian J Dermatol Venereol Leprol; 2023; 89(1):41-46. PubMed ID: 35593293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of hyperpigmentation.
    Pandya AG; Guevara IL
    Dermatol Clin; 2000 Jan; 18(1):91-8, ix. PubMed ID: 10626115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.
    Wang RF; Ko D; Friedman BJ; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):271-288. PubMed ID: 35151757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facial melanoses: Indian perspective.
    Khanna N; Rasool S
    Indian J Dermatol Venereol Leprol; 2011; 77(5):552-63; quiz 564. PubMed ID: 21860153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective clinico-pathological study comparing lichen planus pigmentosus with ashy dermatosis.
    Cheng HM; Chuah SY; Gan EY; Jhingan A; Thng STG
    Australas J Dermatol; 2018 Nov; 59(4):322-327. PubMed ID: 29635779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermoscopy of acquired pigmentary disorders: a comprehensive review.
    Krueger L; Saizan A; Stein JA; Elbuluk N
    Int J Dermatol; 2022 Jan; 61(1):7-19. PubMed ID: 34235719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired dermal macular hyperpigmentation: an overview of the recent updates.
    Shah S; Baskaran N; Vinay K; Bishnoi A; Parsad D; Kumaran MS
    Int J Dermatol; 2023 Dec; 62(12):1447-1457. PubMed ID: 37767951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichen planus pigmentosus-inversus: case report and review of an unusual entity.
    Gaertner E; Elstein W
    Dermatol Online J; 2012 Feb; 18(2):11. PubMed ID: 22398232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular pigmentation of uncertain aetiology revisited: two case reports and a proposed algorithm for clinical classification.
    Chandran V; Kumarasinghe SP
    Australas J Dermatol; 2017 Feb; 58(1):45-49. PubMed ID: 26831572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpigmentation and melasma.
    Rigopoulos D; Gregoriou S; Katsambas A
    J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
    Kumarasinghe SPW; Pandya A; Chandran V; Rodrigues M; Dlova NC; Kang HY; Ramam M; Dayrit JF; Goh BK; Parsad D
    Int J Dermatol; 2019 Mar; 58(3):263-272. PubMed ID: 30176055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
    Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
    J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.